Healthcare -
Biotechnology - NASDAQ - US
$ 8.5847
8.67 %
$ 425 M
Market Cap
-1.71
P/E
RGNX - OTHER ACCUMULATIVE COMPREHENSIVE INCOME LOSS
Other Accumulative Comprehensive Income Loss RGNX - REGENXBIO Inc.
-4.43 M
LAST VALUE
-31.30%
2 YEAR CAGR
-43.81%
5 YEAR CAGR
-3132.77%
10 YEAR CAGR